{"id":"https://openalex.org/W2912290302","doi":"https://doi.org/10.1007/s41669-019-0120-9","title":"Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing","display_name":"Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing","publication_year":2019,"publication_date":"2019-02-05","ids":{"openalex":"https://openalex.org/W2912290302","doi":"https://doi.org/10.1007/s41669-019-0120-9","mag":"2912290302","pmid":"https://pubmed.ncbi.nlm.nih.gov/30721410","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6710305"},"language":"en","primary_location":{"id":"doi:10.1007/s41669-019-0120-9","doi":"https://doi.org/10.1007/s41669-019-0120-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-019-0120-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-019-0120-9.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4254","issn":["2509-4254","2509-4262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s41669-019-0120-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035589649","display_name":"Sabine Vogler","orcid":"https://orcid.org/0000-0003-4853-4397","observed_orcids":["https://orcid.org/0000-0003-4853-4397"]},"institutions":[{"id":"https://openalex.org/I4210122114","display_name":"Gesundheit \u00d6sterreich","ror":"https://ror.org/02m68mv75","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210122114"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Sabine Vogler","raw_affiliation_strings":["WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria. sabine.vogler@goeg.at","WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0003-4853-4397","affiliations":[{"raw_affiliation_string":"WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria. sabine.vogler@goeg.at","institution_ids":["https://openalex.org/I4210122114"]},{"raw_affiliation_string":"WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria","institution_ids":["https://openalex.org/I4210122114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019229545","display_name":"Peter A. Schneider","orcid":"https://orcid.org/0000-0002-4498-5150","observed_orcids":["https://orcid.org/0000-0002-4498-5150"]},"institutions":[{"id":"https://openalex.org/I4210122114","display_name":"Gesundheit \u00d6sterreich","ror":"https://ror.org/02m68mv75","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210122114"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Peter Schneider","raw_affiliation_strings":["WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria","institution_ids":["https://openalex.org/I4210122114"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102806488","display_name":"Nina Zimmermann","orcid":"https://orcid.org/0000-0003-0316-1742","observed_orcids":["https://orcid.org/0000-0003-0316-1742"]},"institutions":[{"id":"https://openalex.org/I4210122114","display_name":"Gesundheit \u00d6sterreich","ror":"https://ror.org/02m68mv75","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210122114"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Nina Zimmermann","raw_affiliation_strings":["WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit \u00d6sterreich GmbH (G\u00d6G/Austrian Public Health Institute), Vienna, Austria","institution_ids":["https://openalex.org/I4210122114"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035589649"],"corresponding_institution_ids":["https://openalex.org/I4210122114"],"apc_list":{"value":2200,"currency":"USD","value_usd":2200},"apc_paid":{"value":2200,"currency":"USD","value_usd":2200},"fwci":6.7871,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.96629951,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"3","issue":"3","first_page":"303","last_page":"309"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.6690000295639038},{"id":"https://openalex.org/keywords/price-evolution","display_name":"price evolution","score":0.5379999876022339},{"id":"https://openalex.org/keywords/cost-containment","display_name":"cost containment","score":0.6110000014305115},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.7070000171661377},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":1.0},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":1.0},{"id":"https://openalex.org/keywords/sofosbuvir","display_name":"sofosbuvir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/european-union","display_name":"European Union","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.4133723974227905},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.4094207286834717}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s41669-019-0120-9","doi":"https://doi.org/10.1007/s41669-019-0120-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-019-0120-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-019-0120-9.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4254","issn":["2509-4254","2509-4262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5688914","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6710305","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6710305","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6710305","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoecon Open","raw_type":"Text"},{"id":"pmid:30721410","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30721410","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - open","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0120-9","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s41669-019-0120-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s41669-019-0120-9","doi":"https://doi.org/10.1007/s41669-019-0120-9","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41669-019-0120-9","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41669-019-0120-9.pdf","source":{"id":"https://openalex.org/S4210206322","display_name":"PharmacoEconomics - Open","issn_l":"2509-4254","issn":["2509-4254","2509-4262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics - Open","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2912290302.pdf","grobid_xml":"https://content.openalex.org/works/W2912290302.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W659344829","https://openalex.org/W1481483667","https://openalex.org/W1495901480","https://openalex.org/W1742637944","https://openalex.org/W1950104841","https://openalex.org/W1981819920","https://openalex.org/W2013010309","https://openalex.org/W2019152670","https://openalex.org/W2068876036","https://openalex.org/W2105693761","https://openalex.org/W2130527149","https://openalex.org/W2194735827","https://openalex.org/W2220044669","https://openalex.org/W2297004729","https://openalex.org/W2343331745","https://openalex.org/W2413116175","https://openalex.org/W2416145228","https://openalex.org/W2483104935","https://openalex.org/W2499068340","https://openalex.org/W2521611852","https://openalex.org/W2570174586","https://openalex.org/W2604289185","https://openalex.org/W2610334677","https://openalex.org/W2746434642","https://openalex.org/W2765157423","https://openalex.org/W2801528409","https://openalex.org/W2891211072","https://openalex.org/W2896589719","https://openalex.org/W2898558208","https://openalex.org/W2898970894","https://openalex.org/W2899085330","https://openalex.org/W2902345891","https://openalex.org/W4246611151","https://openalex.org/W4256452268","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2060736412","https://openalex.org/W3101597178","https://openalex.org/W2163448644","https://openalex.org/W2068876036","https://openalex.org/W2540839584","https://openalex.org/W2899085330","https://openalex.org/W2905916926","https://openalex.org/W2288500903","https://openalex.org/W6889911832","https://openalex.org/W7100064630"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"are":[2,228],"indications":[3],"of":[4,8,33,50,115,148,211],"staggered":[5],"market":[6],"entry":[7],"medicines":[9,15,52,107,151],"in":[10,19,36,60,111,179,188,199,221],"the":[11,29,37,89,96,105,149,197,208,236],"national":[12,81],"markets,":[13],"with":[14,21],"being":[16],"marketed":[17],"first":[18,97],"countries":[20,181],"high":[22],"prices.":[23,201],"This":[24,42],"study":[25],"aimed":[26],"to":[27,192,206,230],"analyse":[28],"availability":[30,178],"and":[31,58,72,85,131,160,163,170,185],"evolution":[32],"medicine":[34],"prices":[35,220],"European":[38,146],"Union":[39],"(EU).":[40],"METHODS:":[41],"research":[43],"was":[44],"performed":[45],"for":[46,104,128,196,224],"an":[47],"illustrative":[48],"sample":[49],"five":[51],"(abiraterone,":[53],"emtricitabine/rilpivirine/tenofovir":[54],"disoproxil,":[55],"fingolimod,":[56],"linagliptin":[57],"sofosbuvir)":[59],"27":[61],"EU":[62,116],"Member":[63,117],"States.":[64],"Price":[65,91,176],"data":[66,103,136,177],"at":[67,154,164,182],"6,":[68],"12,":[69],"18,":[70],"36":[71],"60":[73],"months":[74,159,169],"after":[75,99,141,173],"marketing":[76,100,142,174],"authorisation":[77],"were":[78,108],"retrieved":[79],"from":[80],"administrative":[82],"price":[83,102,135,147,186,213,216,233],"databases":[84],"registers":[86],"accessible":[87],"through":[88],"Pharma":[90],"Information":[92],"service.":[93],"RESULTS:":[94],"In":[95],"year":[98],"authorisation,":[101],"selected":[106],"only":[109,138],"available":[110,137],"a":[112],"small":[113],"number":[114],"States-usually":[118],"high-income":[119],"countries.":[120],"Availability":[121],"increased":[122],"over":[123,235],"time.":[124],"However,":[125],"some":[126,189],"countries,":[127,190],"instance":[129],"Central":[130],"Eastern":[132],"Europe,":[133],"had":[134],"several":[139],"years":[140,162,172],"authorisation.":[143,175],"The":[144],"average":[145,200],"surveyed":[150],"decreased":[152],"by":[153],"least":[155,165],"7.1%":[156],"between":[157,167],"6":[158,168],"3":[161],"9.5%":[166],"5":[171],"lower-income":[180],"later":[183],"stages,":[184],"decreases":[187],"appear":[191],"be":[193],"major":[194],"reasons":[195],"reductions":[198],"CONCLUSIONS:":[202],"If":[203],"policymakers":[204],"aim":[205],"apply":[207],"pricing":[209],"policy":[210],"external":[212],"referencing":[214],"(i.e.":[215],"setting":[217],"based":[218],"on":[219],"other":[222],"countries)":[223],"cost-containment":[225],"purposes,":[226],"they":[227],"recommended":[229],"undertake":[231],"continuous":[232],"revisions":[234],"years.":[237]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}